Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Apple
AAPL
|
$1.35B |
| 2 |
Microsoft
MSFT
|
$1.33B |
| 3 |
S&P Global
SPGI
|
$898M |
| 4 |
Advanced Micro Devices
AMD
|
$845M |
| 5 |
Tesla
TSLA
|
$823M |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
$972M |
| 3 |
Merck
MRK
|
$307M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
$205M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
$182M |
Sector Composition
| 1 | Technology | 25.4% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Blackstone Mortgage Trust
BXMT
$3.32B
| $91M | 0.01% |
2,862,279
-436,727
| -13% | -$13.9M |
|
827
Maximus
MMS
$5.04B
| $90.9M | 0.01% |
1,212,376
+30,915
| +3% | +$2.32M |
|
828
Matsons
MATX
$3.25B
| $90.8M | 0.01% |
753,183
+49,863
| +7% | +$6.01M |
|
829
XPO
XPO
$14.9B
| $90.8M | 0.01% |
1,247,650
-16,829
| -1% | -$1.23M |
|
830
CACI
CACI
$10.6B
| $90.8M | 0.01% |
301,364
-63
| -0% | -$19K |
|
831
Southwest Gas
SWX
$5.68B
| $90.5M | 0.01% |
1,155,910
+122,302
| +12% | +$9.58M |
|
832
Morningstar
MORN
$10.8B
| $90.5M | 0.01% |
331,238
+12,197
| +4% | +$3.33M |
|
833
10x Genomics
TXG
$1.66B
| $90.3M | 0.01% |
1,188,439
+28,984
| +2% | +$2.2M |
|
834
Varonis Systems
VRNS
$6.37B
| $90.3M | 0.01% |
1,899,001
+51,369
| +3% | +$2.44M |
|
|
COHR
835
DELISTED
Coherent Inc
COHR
| $90.3M | 0.01% |
330,153
+11,729
| +4% | +$3.21M |
|
836
RenaissanceRe
RNR
$11.5B
| $90.2M | 0.01% |
569,196
-3,064
| -0.5% | -$486K |
|
837
Jefferies Financial Group
JEF
$13.2B
| $90.2M | 0.01% |
2,744,703
-1,072,379
| -28% | -$35.2M |
|
838
Encompass Health
EHC
$12.5B
| $90.1M | 0.01% |
1,267,096
+37,988
| +3% | +$2.7M |
|
|
ITCI
839
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $90M | 0.01% |
1,470,957
+185,143
| +14% | +$11.3M |
|
840
Dropbox
DBX
$7.69B
| $90M | 0.01% |
3,875,329
-2,486,306
| -39% | -$57.7M |
|
|
VG
841
DELISTED
Vonage Holdings Corporation
VG
| $89.9M | 0.01% |
4,429,082
+128,170
| +3% | +$2.6M |
|
842
Globus Medical
GMED
$8.09B
| $89.8M | 0.01% |
1,217,681
+64,194
| +6% | +$4.74M |
|
843
Acuity Brands
AYI
$10.2B
| $89.8M | 0.01% |
474,116
+2,062
| +0.4% | +$390K |
|
844
Sarepta Therapeutics
SRPT
$1.77B
| $89.7M | 0.01% |
1,148,670
+16,614
| +1% | +$1.3M |
|
845
Douglas Emmett
DEI
$2.71B
| $89.7M | 0.01% |
2,684,641
-174,384
| -6% | -$5.83M |
|
846
Novanta
NOVT
$4.03B
| $89.6M | 0.01% |
629,977
+18,604
| +3% | +$2.65M |
|
847
Rogers Corp
ROG
$1.4B
| $89.2M | 0.01% |
328,208
+8,556
| +3% | +$2.32M |
|
848
Intellia Therapeutics
NTLA
$1.22B
| $89.2M | 0.01% |
1,226,824
-5,668
| -0.5% | -$412K |
|
849
GXO Logistics
GXO
$5.87B
| $89.1M | 0.01% |
1,248,928
+46,654
| +4% | +$3.33M |
|
850
Medpace
MEDP
$13.3B
| $89.1M | 0.01% |
544,358
+7,605
| +1% | +$1.24M |
|